Loading...

Integrated Diagnostics Holdings plc

IDHC.LLSE
Healthcare
Medical - Diagnostics & Research
£0.36
£0.003(0.85%)

Integrated Diagnostics Holdings plc (IDHC.L) Stock Competitors & Peer Comparison

See (IDHC.L) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
IDHC.L£0.36+0.85%206.4M8.88£0.04N/A
0QNO.L£573.20-0.66%39.1B14.50£39.52+0.69%
0KHE.L£87.79-5.44%10.7B14.68£6.16+0.31%
0G8X.L£0.46-1.24%186.1M-0.06-£7.81N/A
DXRX.L£133.50+0.00%112.8M-66.75-£0.02N/A
AGL.L£6.00+0.00%19.4M-1.20-£0.05N/A
YGEN.L£0.51-0.47%16.4M-0.51-£0.01N/A
ABDX.L£6.50+4.00%13.1M-6.75-£0.01N/A
PRM.L£3.04+0.00%9M-3.04-£0.01N/A
VRCI.L£0.55+0.00%7.8M-0.28-£0.02N/A
Showing 1 to 10 of 15 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

IDHC.L vs 0QNO.L Comparison August 2025

IDHC.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IDHC.L stands at 206.4M. In comparison, 0QNO.L has a market cap of 39.1B. Regarding current trading prices, IDHC.L is priced at £0.36, while 0QNO.L trades at £573.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IDHC.L currently has a P/E ratio of 8.88, whereas 0QNO.L's P/E ratio is 14.50. In terms of profitability, IDHC.L's ROE is +0.24%, compared to 0QNO.L's ROE of +0.07%. Regarding short-term risk, IDHC.L is less volatile compared to 0QNO.L. This indicates potentially lower risk in terms of short-term price fluctuations for IDHC.L.Check 0QNO.L's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;